Searched over 200M research papers
10 papers analyzed
These studies suggest that combining lisinopril with diuretics is effective and well-tolerated for treating hypertension and heart failure, improving exercise duration, quality of life, and clinical parameters.
20 papers analyzed
Lisinopril, an angiotensin-converting enzyme (ACE) inhibitor, is commonly used to manage hypertension and heart failure. Diuretics, such as hydrochlorothiazide, are also frequently prescribed for these conditions. Combining these medications can enhance therapeutic outcomes due to their complementary mechanisms of action.
A multicenter, double-blind trial compared the efficacy of lisinopril and hydrochlorothiazide in obese hypertensive patients. Both medications significantly lowered systolic and diastolic blood pressures compared to placebo. However, lisinopril showed a slightly higher efficacy in reducing diastolic pressure and had a more favorable impact on metabolic parameters, such as plasma glucose and serum potassium levels.
Long-term studies have demonstrated that combining lisinopril with a thiazide diuretic, such as trichlormethiazide, effectively maintains blood pressure control over extended periods. This combination allows for lower doses of lisinopril, reducing the risk of side effects like dry cough. Additionally, the diuretic component helps counteract the increase in serum potassium often seen with ACE inhibitors alone.
A study investigating the effects of lisinopril and hydrochlorothiazide on platelet function and blood rheology found that both drugs effectively lowered blood pressure without significantly altering platelet counts or aggregation. However, lisinopril showed a tendency to improve blood rheology parameters, which could potentially reduce the risk of atherosclerotic and thrombotic complications associated with hypertension.
Lisinopril has been compared with other treatments like digoxin and captopril in patients with congestive heart failure (CHF). Studies have shown that lisinopril, when added to a regimen of diuretics and digoxin, significantly improves exercise duration, left ventricular ejection fraction, and overall quality of life. These benefits were more pronounced in patients with renal impairment and those with severely reduced ejection fractions .
In patients with stable CHF, discontinuing diuretics while continuing lisinopril therapy has been explored. Approximately 29% of patients managed to remain diuretic-free, suggesting that lisinopril can maintain hemodynamic stability in certain CHF patients. However, factors like baseline diuretic dose, left ventricular ejection fraction, and history of hypertension were predictive of the need to restart diuretics.
Combining lisinopril with diuretics offers a robust approach to managing hypertension and heart failure. This combination not only enhances blood pressure control but also mitigates some of the metabolic side effects associated with monotherapy. Long-term studies support the efficacy and safety of this combination, making it a valuable option in clinical practice. Further research may continue to elucidate the full benefits and optimal use of these medications in various patient populations.
Most relevant research papers on this topic